Use of Exparel for Postoperative Analgesia Following Bariatric Surgery
Status:
Unknown status
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of liposomal bupivicaine in post operative
analgesia for patients undergoing bariatric surgery when compared to conventional local
analgesia. Patients will be randomly selected to receive either liposomal bupivicaine or
conventional bupivicaine via a transversus abdominal plane block during surgery. Patients
will be followed post-operatively to assess use of narcotics, post-operative pain and nausea
scores, and length of stay.